Drug Class
CDK4/6 inhibitor
Type
brand
Active Ingredient
ribociclib
📋Overview
Kisqali is a prescription medication that belongs to a class of drugs known as CDK4/6 inhibitors. It is primarily used in the management of certain types of breast cancer, particularly hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. Kisqali works by interfering with proteins involved in cell division, helping to slow the growth of cancer cells. It is often used in combination with other therapies as part of a comprehensive cancer treatment plan.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Kisqali
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.